Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (990) Arrow Down
Filter Results: (990) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (990)
    • People  (4)
    • News  (256)
    • Research  (615)
    • Events  (9)
    • Multimedia  (24)
  • Faculty Publications  (396)

Show Results For

  • All HBS Web  (990)
    • People  (4)
    • News  (256)
    • Research  (615)
    • Events  (9)
    • Multimedia  (24)
  • Faculty Publications  (396)
← Page 23 of 990 Results →
  • 16 May 2022
  • News

Baby Formula Is Just the Latest Supply Chain Crisis—We Should Be Asking Why

  • Web

Capstone | MBA

that will advance new drug discoveries and therapeutics with those equally passionate about changing the business of healthcare for the better. 2. The practicalities of business decisions meet the practicalities of hard science. Students... View Details
  • May 2023 (Revised June 2023)
  • Supplement

Novartis (B): Reimagining Medicine

By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Care and Treatment; Business Model; Production; Business Strategy; Pharmaceutical Industry
Citation
Related
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (B): Reimagining Medicine." Harvard Business School Supplement 723-444, May 2023. (Revised June 2023.)
  • Research Summary

Overview

Professor Goh’s primary research interest is applying mathematical models to real-world problems in health care in order to inform, improve, and enhance medical decision making and health policy. His recent work in this domain focuses on developing new methods for... View Details
Keywords: Uncertainty; Optimization; Inventory Management; Health; Decision Making; Supply Chain
  • Article

How to Avoid Executive Stress

By: Thomas J. DeLong
When teaching various groups of executives, the author relates the story of a man addicted to prescription drugs and his brother who is addicted to achievement. Each group relates to these two professionally successful men and sees that they live largely on the edge of... View Details
Keywords: Behavior; Personal Development and Career; Personal Characteristics; Emotions
Citation
Related
DeLong, Thomas J. "How to Avoid Executive Stress." Market Leader (Second Quarter 2012), 50–52.
  • 14 Nov 2017
  • First Look

New Research and Ideas: November 14, 2017

authors provide numerous examples of health care organizations that are taking these steps—and seeing impressive results. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=53460 forthcoming JAMA Cardiology The Central and Unacknowledged Role of the U.S.... View Details
Keywords: Carmen Nobel
  • March 1992
  • Case

Amgen, Inc.: Planning the Unplannable

By: Nitin Nohria
By the early 1990s, Amgen--a pharmaceutical company started little over a decade ago as Applied Molecular Genetics--was within range of becoming a billion-dollar company. With two extremely successful biotechnology drugs on the market, Amgen stood as the largest and... View Details
Keywords: Growth and Development Strategy; Strategic Planning; Success; Risk and Uncertainty; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Nohria, Nitin. "Amgen, Inc.: Planning the Unplannable." Harvard Business School Case 492-052, March 1992.

    Satish K. Tadikonda

    Satish Tadikonda is a Senior Lecturer in the Entrepreneurial Management Unit at Harvard Business School. In the MBA program, Satish teaches The Entrepreneurial Manager, a required first-year MBA course, and Entrepreneurship in Life Sciences, an elective course for... View Details

    • August 2016
    • Simulation

    BDP Pharmaceuticals

    By: Kevin Schulman, Emma Rasiel and Suresh Balu
    Susan Durham has just been hired as the Chief Financial Officer of Blue Devil Pharmaceuticals (BDP). Her charge is to understand the optimal pathway for the development of a novel molecule, BDP-1, to understand the cost of drug development, the market opportunity, and... View Details
    Keywords: Finance; Entrepreneurship
    Citation
    Purchase
    Related
    Schulman, Kevin, Emma Rasiel, and Suresh Balu. "BDP Pharmaceuticals." Harvard Business School Simulation 317-702, August 2016.
    • July 2016
    • Case

    Blue D Pharmaceuticals

    By: Kevin Schulman, Emma Rasiel and Suresh Balu
    Susan Durham has just been hired as the Chief Financial Officer of Blue Devil Pharmaceuticals (BDP). Her charge is to understand the optimal pathway for the development of a novel molecule, BDP-1, to understand the cost of drug development, the market opportunity, and... View Details
    Keywords: Finance; Entrepreneurship
    Citation
    Educators
    Related
    Schulman, Kevin, Emma Rasiel, and Suresh Balu. "Blue D Pharmaceuticals." Harvard Business School Case 317-014, July 2016.
    • February 2022 (Revised September 2022)
    • Case

    InstaDeep: AI Innovation Born in Africa (A)

    By: Shikhar Ghosh and Esel Çekin
    Karim Beguir and Zohra Slim were the co-founders of InstaDeep, a deep tech startup focusing on artificial intelligence (AI) solutions. Instadeep was one of the few companies globally that were partnering with DeepMind, an AI subsidiary of Google [Alphabet Inc.].... View Details
    Keywords: AI; Artificial Intelligence; Entrepreneurship; Operations; Business Subsidiaries; Brands and Branding; Innovation and Invention; Growth and Development Strategy; AI and Machine Learning; Technology Industry; Africa
    Citation
    Educators
    Purchase
    Related
    Ghosh, Shikhar, and Esel Çekin. "InstaDeep: AI Innovation Born in Africa (A)." Harvard Business School Case 822-104, February 2022. (Revised September 2022.)
    • February 2019 (Revised July 2019)
    • Case

    Sales Force Management at Nobel Ilac

    By: Doug J. Chung and Gamze Yucaoglu
    Nobel Ilac was a Turkish generic pharmaceutical company marketing more than 100 drugs in 20 countries and, as of 2017, had over 2,500 employees worldwide. Nobel had implemented a transformation strategy—more specifically, a customer segmentation plan—whereby the sales... View Details
    Keywords: Sales Strategy; Compensation; Employee Retention; Recruiting; Pharmaceuticals; Salesforce Management; Strategy; Organizational Design; Human Resources; Compensation and Benefits; Employees; Retention; Recruitment; Pharmaceutical Industry; Turkey
    Citation
    Educators
    Purchase
    Related
    Chung, Doug J., and Gamze Yucaoglu. "Sales Force Management at Nobel Ilac." Harvard Business School Case 519-067, February 2019. (Revised July 2019.)
    • January 2021
    • Case

    Value-Based Insurance Design at Onex

    By: Joshua Schwartzstein, Amitabh Chandra and Amram Migdal
    The operating executives of Health and Benefits for Onex Partners, Megan Jackson Frye and Sam Camens, faced a challenge: Healthcare costs for employees of Onex’s portfolio companies were continuing to rise above the consumer price index, reflecting broader trends... View Details
    Keywords: Decision Making; Cost vs Benefits; Decision Choices and Conditions; Decisions; Finance; Behavioral Finance; Insurance; Health; Health Care and Treatment; Human Resources; Compensation and Benefits; Markets; Demand and Consumers; Consumer Behavior; Social Psychology; Behavior; Interests; Motivation and Incentives; Perception; Health Industry; Insurance Industry; North America; United States
    Citation
    Educators
    Purchase
    Related
    Schwartzstein, Joshua, Amitabh Chandra, and Amram Migdal. "Value-Based Insurance Design at Onex." Harvard Business School Case 921-023, January 2021.
    • Web

    Overview | MBA

    uncertainties in affecting these opportunities. Develop approaches to ethical dilemmas bedeviling novel therapeutics, including investment in neglected diseases, the provision of life-saving drugs to disadvantaged patients and those in... View Details
    • Article

    Overturning the ACA's Medicaid Expansion Would Likely Decrease Low-Income, Reproductive-Age Women's Healthcare Spending and Utilization

    By: Lucy Chen, Richard G. Frank and Haiden A. Huskamp
    In late 2020, the Supreme Court began hearing a case challenging the Affordable Care Act (ACA), which led to coverage gains for many low-income, reproductive-age women. To explore potential implications of a full ACA repeal for this population, we examined gains... View Details
    Keywords: Medicaid; Women's Health; Health Insurance; Health Care and Treatment; Gender; Insurance; Poverty; Health Industry; United States
    Citation
    Read Now
    Related
    Chen, Lucy, Richard G. Frank, and Haiden A. Huskamp. "Overturning the ACA's Medicaid Expansion Would Likely Decrease Low-Income, Reproductive-Age Women's Healthcare Spending and Utilization." Inquiry 57 (2020).
    • Web

    MS/MBA Biotechnology: Life Sciences | MBA

    new drug discoveries and therapeutics. The program is completed over two academic years, utilizing January terms and time in August at the start of the program. The curriculum emphasizes developing effective business models in the... View Details
    • 2022
    • Working Paper

    Regulatory Incentives for Innovation: The FDA's Breakthrough Therapy Designation

    By: Amitabh Chandra, Jennifer Kao, Kathleen Miller and Ariel D. Stern
    Regulators of new products confront a tradeoff between speeding a new product to market and collecting additional product quality information. The FDA’s Breakthrough Therapy Designation (BTD) provides an opportunity to understand if a regulator can use new policy to... View Details
    Keywords: Research and Development; Governing Rules, Regulations, and Reforms; Product Development
    Citation
    Find at Harvard
    Purchase
    Related
    Chandra, Amitabh, Jennifer Kao, Kathleen Miller, and Ariel D. Stern. "Regulatory Incentives for Innovation: The FDA's Breakthrough Therapy Designation." NBER Working Paper Series, No. 30712, December 2022.
    • September 2021
    • Article

    Trials and Terminations: Learning from Competitors' R&D Failures

    By: Joshua L. Krieger
    I analyze project continuation decisions where firms may resolve uncertainty through news about competitors' research and development (R&D) failures, as well as through their own results. I examine the trade-offs and interactions between product-market competition and... View Details
    Keywords: Research and Development; Projects; Failure; Decision Making; Learning
    Citation
    Find at Harvard
    Read Now
    Related
    Krieger, Joshua L. "Trials and Terminations: Learning from Competitors' R&D Failures." Management Science 67, no. 9 (September 2021).
    • Web

    Faculty & Advisors | MBA

    Underscore VC, she invested in fast growing B2B software startups, including life sciences tech products used by leading biopharma companies across the drug development cycle from R&D to commercial stages. She began her career at Michael... View Details
    • 21 Aug 2007
    • First Look

    First Look: August 21, 2007

    http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=807074   PublicationsPerspectives on Risk and Regulation: The FDA at 100 Author:Arthur A. Daemmrich Publication:Chemical Heritage Press, 2007 Abstract Perspectives on Risk and Regulation: The FDA at 100... View Details
    Keywords: Martha Lagace
    • ←
    • 23
    • 24
    • …
    • 49
    • 50
    • →
    ǁ
    Campus Map
    Harvard Business School
    Soldiers Field
    Boston, MA 02163
    →Map & Directions
    →More Contact Information
    • Make a Gift
    • Site Map
    • Jobs
    • Harvard University
    • Trademarks
    • Policies
    • Accessibility
    • Digital Accessibility
    Copyright © President & Fellows of Harvard College.